Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion type Assertion NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_head.
- NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion wasGeneratedBy ECO_0000203 NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_provenance.
- NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion wasDerivedFrom befree-20140225 NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_provenance.
- NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion SIO_000772 15328326 NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_provenance.
- NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion evidence source_evidence_literature NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_provenance.
- NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_assertion description "[In contrast with SDHD mutation carriers (PGL-1) who have more frequent multifocal paragangliomas, SDHB mutation carriers (PGL-4) are more likely to develop malignant disease and possibly extraparaganglial neoplasias, including renal cell and thyroid carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825582.RAtEAKZHyEiVa-xILwvo7IvFJA_6RCkmwA3Dl5ZQbAYZ4130_provenance.